HUTCHMED (CHINA) LIMITED ORD USD0.1HUTCHMED (CHINA) LIMITED ORD USD0.1HUTCHMED (CHINA) LIMITED ORD USD0.1

HUTCHMED (CHINA) LIMITED ORD USD0.1

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.42 B‬GBP
−0GBP
‪79.35 M‬GBP
‪659.83 M‬GBP
‪500.18 M‬
Beta (1Y)
1.10
Employees (FY)
‪1.99 K‬
Change (1Y)
−37 −1.83%
Revenue / Employee (1Y)
‪422.51 K‬GBP
Net income / Employee (1Y)
‪50.81 K‬GBP

About HUTCHMED (CHINA) LIMITED


CEO
Wei Guo Su
Headquarters
Hong Kong
Founded
2000
FIGI
BBG000P4SQF9
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HCM is 268 GBX — it has decreased by −1.81% in the past 24 hours. Watch HUTCHMED (CHINA) LIMITED ORD USD0.1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HUTCHMED (CHINA) LIMITED ORD USD0.1 stocks are traded under the ticker HCM.
HCM stock has fallen by −6.55% compared to the previous week, the month change is a −9.06% fall, over the last year HUTCHMED (CHINA) LIMITED ORD USD0.1 has showed a −14.24% decrease.
We've gathered analysts' opinions on HUTCHMED (CHINA) LIMITED ORD USD0.1 future price: according to them, HCM price has a max estimate of 635.97 GBX and a min estimate of 358.54 GBX. Watch HCM chart and read a more detailed HUTCHMED (CHINA) LIMITED ORD USD0.1 stock forecast: see what analysts think of HUTCHMED (CHINA) LIMITED ORD USD0.1 and suggest that you do with its stocks.
HCM reached its all-time high on Jun 30, 2021 with the price of 656 GBX, and its all-time low was 4 GBX and was reached on Dec 17, 2008. View more price dynamics on HCM chart.
See other stocks reaching their highest and lowest prices.
HCM stock is 3.76% volatile and has beta coefficient of 1.10. Track HUTCHMED (CHINA) LIMITED ORD USD0.1 stock price on the chart and check out the list of the most volatile stocks — is HUTCHMED (CHINA) LIMITED ORD USD0.1 there?
Today HUTCHMED (CHINA) LIMITED ORD USD0.1 has the market capitalization of ‪2.44 B‬, it has decreased by −2.46% over the last week.
Yes, you can track HUTCHMED (CHINA) LIMITED ORD USD0.1 financials in yearly and quarterly reports right on TradingView.
HUTCHMED (CHINA) LIMITED ORD USD0.1 is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
HCM earnings for the last half-year are 0.02 GBX per share, whereas the estimation was −0.06 GBX, resulting in a 138.22% surprise. The estimated earnings for the next half-year are −0.01 GBX per share. See more details about HUTCHMED (CHINA) LIMITED ORD USD0.1 earnings.
HUTCHMED (CHINA) LIMITED ORD USD0.1 revenue for the last half-year amounts to ‪241.79 M‬ GBX, despite the estimated figure of ‪252.59 M‬ GBX. In the next half-year revenue is expected to reach ‪302.09 M‬ GBX.
HCM net income for the last half-year is ‪20.43 M‬ GBP, while the previous report showed ‪−53.30 M‬ GBP of net income which accounts for 138.33% change. Track more HUTCHMED (CHINA) LIMITED ORD USD0.1 financial stats to get the full picture.
No, HCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has ‪1.99 K‬ employees. See our rating of the largest employees — is HUTCHMED (CHINA) LIMITED ORD USD0.1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUTCHMED (CHINA) LIMITED ORD USD0.1 EBITDA is ‪−87.22 M‬ GBP, and current EBITDA margin is 3.05%. See more stats in HUTCHMED (CHINA) LIMITED ORD USD0.1 financial statements.
Like other stocks, HCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUTCHMED (CHINA) LIMITED ORD USD0.1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUTCHMED (CHINA) LIMITED ORD USD0.1 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUTCHMED (CHINA) LIMITED ORD USD0.1 stock shows the sell signal. See more of HUTCHMED (CHINA) LIMITED ORD USD0.1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.